ResMed announced today that it launched its new AirTouch N30i continuous positive airway pressure (CPAP) mask.

ResMed has launched several patient-centric products designed to enhance their therapy for sleep apnea, including several new ...

NEW YORK and SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today unveiled its 2030 Strategy to drive growth, profitability, and shareholder returns at an Investor Day ...

New commercial excellence and demand generation initiatives will drive more patients into ResMed’s funnel, where they will be served by a robust roadmap of new products, such as the AirTouch ...

“New commercial excellence and demand generation initiatives will drive more patients into ResMed’s funnel, where they will be served by a robust road map of new products, such as the AirTouch ...

In a separate release, ResMed announced the launch of AirTouch N30i, a first-of-its-kind innovation in CPAP masks. AirTouch N30i is a fabric-wrapped frame featuring a soft, breathable and moisture ...

Needham analyst Michael Matson maintained a Hold rating on Resmed (RMD – Research Report) today. The company’s shares closed yesterday at $244.12. According to TipRanks, Matson is an analyst ...

But ResMed, which makes sleep apnea devices, sees an opportunity. The device maker has started presenting data suggesting GLP-1 users are more likely to go on to use CPAP eventually.